OBJECTIVES: Whole-blood RNA for microarray analysis is easily accessible but contains a large proportion of globin mRNA that interferes with the accurate assessment of other genes. This study investigated the biological significance of genes whose expression was unmasked by globin mRNA reduction in peripheral blood. DESIGN AND METHODS: Samples were collected from healthy subjects using the PAXgene Blood RNA System, and globin mRNA was depleted using GLOBINclear. Genes exhibiting consistent changes in expression on Affymetrix HU133A 2.0 arrays were characterized in three main areas of gene ontology--molecular function, biological process, and cellular component. RESULTS: Globin reduction permitted detection of 2652+/-395 additional genes per assay. Genes unmasked by globin reduction include low abundance transcripts that function primarily as molecular binding proteins and catalytic enzymes in biological processes including transcription, replication, and intracellular transport and signalling. Protein products of these genes are preferentially associated with membranes and the nucleus. CONCLUSIONS: Additional genes detectable only after globin reduction in whole-blood RNA function in a variety of biological processes that may be important to diverse fields of study.
OBJECTIVES: Whole-blood RNA for microarray analysis is easily accessible but contains a large proportion of globin mRNA that interferes with the accurate assessment of other genes. This study investigated the biological significance of genes whose expression was unmasked by globin mRNA reduction in peripheral blood. DESIGN AND METHODS: Samples were collected from healthy subjects using the PAXgene Blood RNA System, and globin mRNA was depleted using GLOBINclear. Genes exhibiting consistent changes in expression on Affymetrix HU133A 2.0 arrays were characterized in three main areas of gene ontology--molecular function, biological process, and cellular component. RESULTS: Globin reduction permitted detection of 2652+/-395 additional genes per assay. Genes unmasked by globin reduction include low abundance transcripts that function primarily as molecular binding proteins and catalytic enzymes in biological processes including transcription, replication, and intracellular transport and signalling. Protein products of these genes are preferentially associated with membranes and the nucleus. CONCLUSIONS: Additional genes detectable only after globin reduction in whole-blood RNA function in a variety of biological processes that may be important to diverse fields of study.
Authors: Martin Letzkus; Evert Luesink; Sandrine Starck-Schwertz; Marc Bigaud; Fareed Mirza; Nicole Hartmann; Bernhard Gerstmayer; Uwe Janssen; Andreas Scherer; Martin M Schumacher; Aurelie Verles; Alessandra Vitaliti; Nanguneri Nirmala; Keith J Johnson; Frank Staedtler Journal: Clin Transl Med Date: 2014-11-13
Authors: Anastasios Mastrokolias; Johan T den Dunnen; Gertjan B van Ommen; Peter A C 't Hoen; Willeke M C van Roon-Mom Journal: BMC Genomics Date: 2012-01-18 Impact factor: 3.969
Authors: Sally A Madsen-Bouterse; Roberto Romero; Adi L Tarca; Juan Pedro Kusanovic; Jimmy Espinoza; Chong Jai Kim; Jung-Sun Kim; Samuel S Edwin; Ricardo Gomez; Sorin Draghici Journal: Am J Reprod Immunol Date: 2010-01 Impact factor: 3.886
Authors: Josine L Min; Amy Barrett; Tim Watts; Fredrik H Pettersson; Helen E Lockstone; Cecilia M Lindgren; Jennifer M Taylor; Maxine Allen; Krina T Zondervan; Mark I McCarthy Journal: BMC Genomics Date: 2010-02-08 Impact factor: 3.969
Authors: Mary E Winn; Matthew A Zapala; Iiris Hovatta; Victoria B Risbrough; Elizabeth Lillie; Nicholas J Schork Journal: Mamm Genome Date: 2010-05-16 Impact factor: 2.957
Authors: Mark L Parrish; Chris Wright; Yarek Rivers; David Argilla; Heather Collins; Brendan Leeson; Andrey Loboda; Michael Nebozhyn; Matthew J Marton; Serguei Lejnine Journal: J Transl Med Date: 2010-09-25 Impact factor: 5.531
Authors: Ze Tian; Nathan Palmer; Patrick Schmid; Hui Yao; Michal Galdzicki; Bonnie Berger; Erxi Wu; Isaac S Kohane Journal: PLoS One Date: 2009-04-17 Impact factor: 3.240
Authors: Kristina Vartanian; Rachel Slottke; Timothy Johnstone; Amanda Casale; Stephen R Planck; Dongseok Choi; Justine R Smith; James T Rosenbaum; Christina A Harrington Journal: BMC Genomics Date: 2009-01-05 Impact factor: 3.969